Jefferies Group LLC:企業の戦略・SWOT・財務分析

◆英語タイトル:Jefferies Group LLC - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4301
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Jefferies Group LLC – Strategy, SWOT and Corporate Finance Report
Summary

Jefferies Group LLC – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Jefferies Group LLC (JGL), a subsidiary of Jefferies Financial Group Inc, is a financial services company that offers investment banking, sales and trading, and wealth management solutions. Investment banking includes equity and debt capital market solutions, financial advisory, mergers and acquisitions, restructuring, and recapitalization services. The company conducts sales and trading activities across equities, fixed income and foreign exchange products. It manages a wide range of alternative asset management platforms across an array of asset classes and investment strategies. The company also provides services such as research and strategy, corporate lending and real estate finance, prime brokerage, and equity finance. It has presence in Asia, Europe, and Americas. JGL is headquartered in New York, the US.

Scope

- Detailed information on Jefferies Group LLC required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Jefferies Group LLC in the form of a SWOT analysis
- An in-depth view of the business model of Jefferies Group LLC including a breakdown and examination of key business segments
- Intelligence on Jefferies Group LLC’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Jefferies Group LLC, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Jefferies Group LLC and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Jefferies Group LLC as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Jefferies Group LLC’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Jefferies Group LLC: Company Overview
Jefferies Group LLC: Overview and Key Facts
Jefferies Group LLC: Overview
Jefferies Group LLC: Key Facts
Jefferies Group LLC: Key Employees
Jefferies Group LLC: Key Employee Biographies
Jefferies Group LLC: Major Products and Services
Jefferies Group LLC: Company History
Jefferies Group LLC: Management Statement
Jefferies Group LLC: Locations and Subsidiaries
Jefferies Group LLC: Key Competitors
Jefferies Group LLC: Company Analysis
Jefferies Group LLC: Business Description
Jefferies Group LLC: SWOT Analysis
Jefferies Group LLC: SWOT Overview
Jefferies Group LLC: Strengths
Jefferies Group LLC: Weaknesses
Jefferies Group LLC: Opportunities
Jefferies Group LLC: Threats
Jefferies Group LLC: Corporate Financial Deals Activity
Jefferies Group LLC: Financial Deals Overview
Jefferies Group LLC: Targets and Partners
Jefferies Group LLC: Top Deals 2016 – 2020YTD*
Jefferies Group LLC: Advisors
Jefferies Group LLC: Top Legal Advisors
Jefferies Group LLC: Top Financial Advisors
Jefferies Group LLC: Corporate Venturing
Jefferies Group LLC: Capital Raising
Jefferies Group LLC: Recent Developments
Jefferies Group LLC: News and Events Summary
Jefferies Group LLC: Business Expansion
Jefferies Group LLC: Business Reorganization
Jefferies Group LLC: Contracts
Jefferies Group LLC: Corporate Governance
Jefferies Group LLC: Financial Deals
Jefferies Group LLC: Financial Performance
Jefferies Group LLC: Market Developments
Jefferies Group LLC: Red Flags/DistressSignals
Jefferies Group LLC: Regulatory and Legal Events
Jefferies Group LLC: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Jefferies Group LLC: Key Facts
Table 2: Jefferies Group LLC: Key Employees
Table 3: Jefferies Group LLC: Company History
Table 4: Jefferies Group LLC: Locations and Subsidiaries
Table 5: Jefferies Group LLC: Key Competitors
Table 6: Jefferies Group LLC: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Jefferies Group LLC: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Jefferies Group LLC: Targets and Partners
Table 9: Jefferies Group LLC: Top Deals 2016 - 2020YTD*
Table 10: Jefferies Group LLC: Legal Advisor Ranking by Value (US$m)
Table 11: Jefferies Group LLC: Financial Advisor Ranking by Value (US$m)
Table 12: Jefferies Group LLC: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 13: Jefferies Group LLC: Corporate Venturing by Geography (2016 - YTD*2020)
Table 14: Jefferies Group LLC: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 15: Jefferies Group LLC: Capital Raising by Deal Type (2016 - YTD*2020)
Table 16: Jefferies Group LLC: News and Events Summary
Table 17: Jefferies Group LLC: Business Expansion
Table 18: Jefferies Group LLC: Business Reorganization
Table 19: Jefferies Group LLC: Contracts
Table 20: Jefferies Group LLC: Corporate Governance
Table 21: Jefferies Group LLC: Financial Deals
Table 22: Jefferies Group LLC: Financial Performance
Table 23: Jefferies Group LLC: Market Developments
Table 24: Jefferies Group LLC: Red Flags/DistressSignals
Table 25: Jefferies Group LLC: Regulatory and Legal Events
Table 26: Jefferies Group LLC: Strategy and Operations

★海外企業調査レポート[Jefferies Group LLC:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Approach Resources Inc (AREXQ):企業の財務・戦略的SWOT分析
    Approach Resources Inc (AREXQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Morphotek Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Morphotek Inc (Morphotek), a subsidiary of Eisai Inc, is a clinical-stage biotechnology company that develops monoclonal antibodies, antibody drug conjugates, and bispecific antibodies to treat cancer, inflammatory and infectious diseases. Its pipeline product portfolio includes farletuzumab …
  • Noven Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報
    Noven Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Noven Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Cypark Resources Berhad (CYPARK):電力:M&Aディール及び事業提携情報
    Summary Cypark Resources Berhad (CRB) is a clean technology company that offers environmental engineering services. The company offers engineering and technology services on transforming dump sites to an economic and environmental boon. Its services include environmental remediation, integrated wast …
  • Genfit SA (GNFT)-医療機器分野:企業M&A・提携分析
    Summary Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company’s product pipeline comprise GFT505, TGFTX1, TGFTX3, TGFTX4, TGFTX5 and SAN/GFT-2. Its TGFTX1 can be …
  • Tampa Electric Co:電力:M&Aディール及び事業提携情報
    Summary Tampa Electric Company (TEC), a subsidiary of Emera Inc., is an energy utility. It conducts the generation, purchase, transmission, distribution and sale of electricity and the distribution, purchase and sale of natural gas in Florida. The service area for electric operations covers West Cen …
  • Codan Radio Communications:企業の戦略・SWOT・財務情報
    Codan Radio Communications - Strategy, SWOT and Corporate Finance Report Summary Codan Radio Communications - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Taiwan Financial Holding Co Ltd:企業の戦略・SWOT・財務分析
    Taiwan Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Taiwan Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Cutera Inc (CUTR):企業の財務・戦略的SWOT分析
    Cutera Inc (CUTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Addvalue Technologies Limited (A31):企業の財務・戦略的SWOT分析
    Addvalue Technologies Limited (A31) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • North Asia Strategic Holdings Limited:企業の戦略・SWOT・財務分析
    North Asia Strategic Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary North Asia Strategic Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • KKR & Co. Inc:企業の戦略・SWOT・財務分析
    KKR & Co. Inc - Strategy, SWOT and Corporate Finance Report Summary KKR & Co. Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Merck KGaA (MRK):企業の財務・戦略的SWOT分析
    Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Newron Pharmaceuticals SpA (NWRN):製薬・医療:M&Aディール及び事業提携情報
    Summary Newron Pharmaceuticals SpA (Newron) is a research-based biopharmaceutical company which focuses on the discovery, development and commercialization of novel therapeutic drugs for the treatment of central nervous system disorders and pain. The company’s marketed product, Xadago (safinamide), …
  • Kinden Corporation:企業の戦略・SWOT・財務情報
    Kinden Corporation - Strategy, SWOT and Corporate Finance Report Summary Kinden Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Centogene AG:医療機器:M&Aディール及び事業提携情報
    Summary Centogene AG (Centogene) is a biotechnology and genetic diagnostic company which offers genetic testing for rare hereditary disorders. The company provides diagnostic services including whole genome sequencing, whole exome sequencing, clinical exome sequencing, NGS panel genomic, carrier scr …
  • Lung Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lung Therapeutics Inc (Lung Therapeutics) is a pharmaceutical company that offers orphan drug indications for lung injury and disease. The company provides service to underserved, life-threatening lung condition pursues an innovative treatment. Its pipeline candidates include LTI-01, single …
  • Sete Brasil Participacoes SA:企業の戦略的SWOT分析
    Sete Brasil Participacoes SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Tizona Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tizona Therapeutics Inc (Tizona Therapeutics) is an immunology company which develops treatments for cancer and autoimmune disorders. Its lead product candidate anti-CD39 antibody inhibits the breakdown of excessive ATP released from dying tumor cells to immune suppressive adenosine leading …
  • Wacoal Holdings Corp (3591):企業の財務・戦略的SWOT分析
    Wacoal Holdings Corp (3591) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆